A

Apontis Pharma AG
XETRA:APPH

Watchlist Manager
Apontis Pharma AG
XETRA:APPH
Watchlist
Price: 10.1 EUR
Market Cap: 85.9m EUR
Have any thoughts about
Apontis Pharma AG?
Write Note

Apontis Pharma AG
Investor Relations

APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Bruno Wohlschlegel
CEO & Chairman of Management Board
No Bio Available
Mr. Thomas Milz
Chief Product Officer & Deputy Chairman of Management Board
No Bio Available
Mr. Thomas Zimmermann
CFO & Member of Management Board
No Bio Available
Mr. Harald Weyand
Head of Marketing
No Bio Available
Ms. Susanne Böhm
Head of HR
No Bio Available
Dr. Olaf Randerath
Head of Medicine
No Bio Available
Dr. Susanne Endreß
Head of QA, Drug Safety & Regulatory Affairs
No Bio Available

Contacts

Address
NORDRHEIN-WESTFALEN
Monheim Am Rhein
Alfred-Nobel-Strasse 10
Contacts